{"id":44675,"date":"2026-10-26T16:54:07","date_gmt":"2026-10-26T16:54:07","guid":{"rendered":"https:\/\/www.europesays.com\/be\/44675\/"},"modified":"2026-10-26T16:54:07","modified_gmt":"2026-10-26T16:54:07","slug":"belga-share-belgian-pharmaceutical-sector-concerned-about-declining-figures","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/be\/44675\/","title":{"rendered":"Belga Share &#8211; Belgian pharmaceutical sector concerned about declining figures"},"content":{"rendered":"<p>Investment, exports, and employment in the biopharmaceutical sector have declined for several years. Pharmaceutical exports, worth 73 billion euros a year, fell by 6.8 per cent in 2025. Investment fell by 12 per cent in 2024 and by 4 per cent in 2025, while more than 400 jobs were lost between 2023 and 2025.<\/p>\n<p>   The figures may deteriorate further. Pharmaceutical company GSK, one of the country&#8217;s largest private employers, announced in October that it intended to cut more than 1,200 jobs.<\/p>\n<p>   Ven warns of the impact of declining figures on research and development, as well as on universities, hospitals and research centres.<\/p>\n<p>   The biopharmaceutical sector is calling on the government for greater support and protection by highlighting the benefits for patients. For example, the number of people surviving breast cancer has risen by 18 per cent over the past decade; the number of children with RSV has fallen by more than 3,600 cases; and new treatments can help thousands of people with migraines.<\/p>\n<p>   Through a &#8220;Life Science Declaration&#8221;, the sector is calling for a clear strategy to strengthen and anchor Belgium&#8217;s biopharmaceutical sector.<\/p>\n<p>The initial translation of this content was generated by AI. All facts, context, and language have subsequently been verified and validated by a human editorial team. <br \/><a href=\"https:\/\/belga.be\/ai-disclaimer-belga-english\/\" rel=\"nofollow noopener\" target=\"_blank\">Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Investment, exports, and employment in the biopharmaceutical sector have declined for several years. Pharmaceutical exports, worth 73 billion&hellip;\n","protected":false},"author":2,"featured_media":44676,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[4],"tags":[14487,22623,7,14488,16542,9061,16543],"class_list":["post-44675","post","type-post","status-publish","format-standard","has-post-thumbnail","category-belgium","tag-belga-english","tag-belgian-pharmaceutical-sector-concerned-about-declining-figures","tag-belgium","tag-economy-and-money","tag-labor-market","tag-science","tag-unions-and-entrepreneurship"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@be\/117508261015688595","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/be\/wp-json\/wp\/v2\/posts\/44675","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/be\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/be\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be\/wp-json\/wp\/v2\/comments?post=44675"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/be\/wp-json\/wp\/v2\/posts\/44675\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be\/wp-json\/wp\/v2\/media\/44676"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/be\/wp-json\/wp\/v2\/media?parent=44675"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/be\/wp-json\/wp\/v2\/categories?post=44675"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/be\/wp-json\/wp\/v2\/tags?post=44675"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}